Cornea Department, Dr. Shroff's Charity Eye Hospital, Delhi, India.
Cornea and Stem Cells Department, Dr. Shroff's Charity Eye Hospital, Delhi, India.
Indian J Ophthalmol. 2024 Aug 1;72(8):1124-1129. doi: 10.4103/IJO.IJO_3108_23. Epub 2024 Jul 29.
To assess outcomes of keratoplasty performed in patients diagnosed with keratitis caused by Pythium insidiosum (PI).
Retrospective review.
Preoperative, intra operative and post operative data of patients diagnosed with PI keratitis and who underwent keratoplasty for their condition from January 2020 to December 2021 were collected from the central patient database of a tertiary eye care hospital in India. The data were analyzed for anatomic success, elimination of infection, graft survival, incidence of repeat keratoplasty, final visual acuity and varied complications.
In total, 16 eyes underwent penetrating keratoplasty for PI keratitis during the study period. Mean time to keratoplasty from onset of symptoms was 31.3 days and mean graft size was 10.4 mm. Nine out of the 16 cases had recurrence of infection following surgery, seven of which required a repeat keratoplasty for elimination of infection. Mean graft size for repeat keratoplasty performed in recurrent cases was 11.7 mm. Globe was successfully salvaged in 14 out of 16 patients (87.5 %). Three grafts remained clear at 6-month follow up while 11 grafts failed. Mean improvement in uncorrected visual acuity from 2.32 to 2.04 logMAR was observed at last follow up. Endo-exudates, graft infiltration, graft dehiscence, secondary glaucoma and retinal detachment were the various complications noted after keratoplasty.
PI keratitis is a tenacious and potentially blinding condition. Keratoplasty remains the choice of treatment in this condition, however recurrence of disease and graft failure are common. Large sized grafts, meticulous per-operative removal of infection, adjuvant cryotherapy, and intraoperative and post operative use of antibiotics can help in improving outcome of keratoplasty in these patients.
评估针对由棘孢木霉(PI)引起的角膜炎患者进行的角膜移植术的结果。
回顾性研究。
从印度一家三级眼科医院的中央患者数据库中收集了 2020 年 1 月至 2021 年 12 月期间诊断为 PI 角膜炎并接受角膜移植术治疗的患者的术前、术中及术后数据。对解剖学成功率、感染消除、移植物存活率、重复角膜移植的发生率、最终视力和各种并发症进行了分析。
在研究期间,共有 16 只眼因 PI 角膜炎而行穿透性角膜移植术。从症状发作到行角膜移植的平均时间为 31.3 天,平均移植物大小为 10.4 毫米。16 例中有 9 例术后感染复发,其中 7 例需要再次行角膜移植以消除感染。复发性病例中重复角膜移植的平均移植物大小为 11.7 毫米。在 16 例患者中,有 14 例(87.5%)眼球成功保存。3 个移植物在 6 个月随访时仍保持清晰,11 个移植物失败。末次随访时,未矫正视力从 2.32 提高到 2.04 logMAR。角膜移植术后观察到的各种并发症包括眼内渗出物、移植物浸润、移植物裂开、继发性青光眼和视网膜脱离。
PI 角膜炎是一种顽强且可能致盲的疾病。在这种情况下,角膜移植仍然是治疗的首选,但疾病复发和移植物失败很常见。大尺寸移植物、术中仔细清除感染、辅助冷冻疗法以及术中及术后使用抗生素有助于改善此类患者的角膜移植效果。